Artigo Acesso aberto Revisado por pares

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection

2014; American Medical Association; Volume: 312; Issue: 4 Linguagem: Inglês

10.1001/jama.2014.7734

ISSN

1538-3598

Autores

Mark Sulkowski, Susanna Naggie, Jacob Lalezari, W. Jeffrey Fessel, Karam Mounzer, Margaret C. Shuhart, Anne F. Luetkemeyer, David M. Asmuth, Anuj Gaggar, Liyun Ni, Evguenia S. Svarovskaia, Diana M. Brainard, William T. Symonds, G. Mani Subramanian, John G. McHutchison, M. Rodríguez‐Torres, Douglas T. Dieterich,

Tópico(s)

Liver Disease Diagnosis and Treatment

Resumo

Treatment of hepatitis C virus (HCV) infection in patients also infected with human immunodeficiency virus (HIV) has been limited due to drug interactions with antiretroviral therapies (ARTs) and the need to use interferon.

Referência(s)